Analysis of current trends in pharmaceutical brand lifecycle management with recommendations for creating the optimal brand lifecycle management plan and discussion of commonly used lifecycle management strategies with case studies.

This report analyzes the size, structure and competitive landscape of the global generics market.

Analysis of the competitive landscape and the recent changes in antidyslipidemics across seven major markets. Explores the key events that are likely to impact the performance of the antidyslipidemics, and provides sales forecasts to 2017.

This management report critically analyzes the changing market conditions and the impact of these opportunities on the generics industry and multinational R&D companies.

Opioid abuse is a growing medical challenge, yet few developments have been made in its treatment in recent years. The market requires clarification of the goals of therapy - to remove the addictive behavior or to just manage the addiction and modify t

There is a plethora of cytotoxics on the market but only a few dominate in terms of sales. Yet, patents for major drugs are expected to expire in the short to mid term, and sales will decrease significantly due to generic exposure. The impact of generi

Antibacterial players are currently facing significant hurdles in terms of increasing and maintaining product revenue. These include growing resistance across classes, greater restrictions relating to the use of antibacterials and an expected increase

Report which analyzes the current operational and analytical CRM practises and outlines in detail future developments that will increase the return on investment (ROI) within sales, marketing and customer fulfilment activities.

This report outlines key generics players and the strategies they are using to capture a larger market share of the drugs market.

Use this report to better understand and act on the range of options available to branded companies defending products against generic threats.